JP2019504859A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504859A5
JP2019504859A5 JP2018542269A JP2018542269A JP2019504859A5 JP 2019504859 A5 JP2019504859 A5 JP 2019504859A5 JP 2018542269 A JP2018542269 A JP 2018542269A JP 2018542269 A JP2018542269 A JP 2018542269A JP 2019504859 A5 JP2019504859 A5 JP 2019504859A5
Authority
JP
Japan
Prior art keywords
layer
inert core
pharmaceutical
pharmaceutical bead
bead composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018542269A
Other languages
English (en)
Japanese (ja)
Other versions
JP6902043B2 (ja
JP2019504859A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/016934 external-priority patent/WO2017139331A1/en
Publication of JP2019504859A publication Critical patent/JP2019504859A/ja
Publication of JP2019504859A5 publication Critical patent/JP2019504859A5/ja
Priority to JP2021101599A priority Critical patent/JP2021152050A/ja
Application granted granted Critical
Publication of JP6902043B2 publication Critical patent/JP6902043B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018542269A 2016-02-11 2017-02-08 フマル酸ジメチルを含む医薬ビーズ製剤 Expired - Fee Related JP6902043B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021101599A JP2021152050A (ja) 2016-02-11 2021-06-18 フマル酸ジメチルを含む医薬ビーズ製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662294054P 2016-02-11 2016-02-11
US62/294,054 2016-02-11
PCT/US2017/016934 WO2017139331A1 (en) 2016-02-11 2017-02-08 Pharmaceutical bead formulations comprising dimethyl fumarate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021101599A Division JP2021152050A (ja) 2016-02-11 2021-06-18 フマル酸ジメチルを含む医薬ビーズ製剤

Publications (3)

Publication Number Publication Date
JP2019504859A JP2019504859A (ja) 2019-02-21
JP2019504859A5 true JP2019504859A5 (https=) 2020-03-19
JP6902043B2 JP6902043B2 (ja) 2021-07-14

Family

ID=58057304

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018542269A Expired - Fee Related JP6902043B2 (ja) 2016-02-11 2017-02-08 フマル酸ジメチルを含む医薬ビーズ製剤
JP2021101599A Pending JP2021152050A (ja) 2016-02-11 2021-06-18 フマル酸ジメチルを含む医薬ビーズ製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021101599A Pending JP2021152050A (ja) 2016-02-11 2021-06-18 フマル酸ジメチルを含む医薬ビーズ製剤

Country Status (12)

Country Link
US (2) US11033509B2 (https=)
EP (1) EP3413879A1 (https=)
JP (2) JP6902043B2 (https=)
KR (1) KR20180108814A (https=)
CN (1) CN108778256A (https=)
AU (1) AU2017217464B2 (https=)
CA (1) CA3013472A1 (https=)
EA (1) EA201891803A1 (https=)
IL (1) IL261073A (https=)
MA (1) MA44010A (https=)
MX (1) MX391749B (https=)
WO (1) WO2017139331A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6902043B2 (ja) * 2016-02-11 2021-07-14 バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. フマル酸ジメチルを含む医薬ビーズ製剤
BR112022012199A2 (pt) * 2020-01-17 2022-09-13 Nestle Sa Forma de dosagem com péletes de melatonina de liberação sustentada
AU2022285951A1 (en) 2021-06-04 2024-01-04 Zim Laboratories Limited Delayed release compositions of dimethyl fumarate
CN115300616A (zh) * 2022-08-24 2022-11-08 韩永刚 一种单胃动物用的肠溶葡萄糖氧化酶固体分散体
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2801354T (lt) * 2004-10-08 2017-06-26 Forward Pharma A/S Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
US20080187579A1 (en) * 2007-02-01 2008-08-07 Pavan Bhat Extended-release dosage form
NZ627980A (en) * 2012-02-07 2016-12-23 Biogen Ma Inc Pharmaceutical compositions containing dimethyl fumarate
US20150079180A1 (en) * 2013-09-18 2015-03-19 Xenoport, Inc. Nanoparticle compositions of dimethyl fumarate
EP3079663A1 (en) 2013-12-13 2016-10-19 Biogen MA Inc. Controlled release dosage form for once daily administration of dimethyl fumarate
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
MX387092B (es) * 2015-06-17 2025-03-19 Biogen Ma Inc Particulas de dimetilfumarato y composiciones farmaceuticas de estas.
CN104971048B (zh) * 2015-07-01 2019-01-18 上海汇伦医药科技有限公司 富马酸二甲酯肠溶微丸及其制备方法
JP6902043B2 (ja) * 2016-02-11 2021-07-14 バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. フマル酸ジメチルを含む医薬ビーズ製剤

Similar Documents

Publication Publication Date Title
JP6457458B2 (ja) 時限パルス放出システム
AU2009236271B2 (en) Compositions comprising weakly basic drugs and controlled-release dosage forms
JP6843748B2 (ja) フマル酸ジメチルを含む医薬ビーズ製剤
US20210220281A1 (en) Oral pharmaceutical compositions of mesalazine
US20210369629A1 (en) Pharmaceutical bead formulations comprising dimethyl fumarate
JP2019504859A5 (https=)
JP2017534668A5 (https=)
CN101530387B (zh) 口服迟释药物制剂
JP2018184360A (ja) 経口投与用の腸溶性徐放性製剤